TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07582432: A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Mult

Sponsor: Grifols Biologicals, LLC · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 49 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$1,771,308

Rescue Site Savings

+$1,180,872

Unlock Full NCT07582432 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07582432 Rescue Dossier →